Navigation Links
Boston Scientific Announces Its Schedule for Heart Rhythm Society Scientific Sessions
Date:5/2/2011

NATICK, Mass., May 2, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced its schedule of major events and sponsored research at the 32nd Annual Scientific Sessions of the Heart Rhythm Society (HRS), May 4 – 7 in San Francisco.  The scheduled clinical presentations will provide new insights for physicians who treat patients with heart disorders including sudden cardiac arrest, atrial fibrillation and heart failure.

Schedule of Events (All times are PT, with events to be held at the Moscone Center unless otherwise indicated.)

Wednesday, May 4

  • 23rd Annual Michel Mirowski Sudden Cardiac Arrest Symposium and Award Presentation.  The Company will sponsor the 23rd Annual Michel Mirowski Sudden Cardiac Arrest Symposium and Award Presentation from 6 to 9 p.m. in the Yerba Buena Salon 9 Ballroom at the San Francisco Marriott Marquis Hotel.  The event will begin with a welcome from Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management for Boston Scientific, followed by recognition of program moderator and 2010 award recipient, Jose Jalife, M.D.  The ceremony will also honor this year's Mirowski Award recipient, Silvia Priori, M.D., Ph.D., with an award presentation by Ariella Mirowski Rosengard, M.D.  It will culminate with presentations by Dr. Priori, Arthur Moss, M.D., and Jagmeet Singh, M.D., Ph.D., focusing on sudden cardiac death, cardiac resynchronization therapy and left ventricular lead strategies.
  • The Association of Atrial Fibrillation, ICD and CRT-D Shocks and Mortality in Patients Participating in Remote Device Follow-Up.  David A. Cesario, M.D., Michael Cao, M.D., Brian Powell, M.D., Yong-Mei Cha, M.D., Samuel Asirvatham, M.D., John Day, M.D., Nicholas Wold, M.S., F. Roosevelt Gilliam, III, M.D., and Leslie A. Saxon, M.D., will present findings du
    '/>"/>

  • SOURCE Boston Scientific Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Unilife to Present at the 36th Annual Deutsche Bank Health Care Conference on Monday, May 2, 2011 in Boston
    2. Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System
    3. Boston Scientific Announces Results for First Quarter Ended March 31, 2011
    4. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
    5. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
    6. Boston Scientific ION™ Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data
    7. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
    8. Boston Scientific Announces Its ACC 2011 Schedule
    9. Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
    10. Boston Scientific to Webcast Analyst Event
    11. Boston Scientific to Present at Barclays Capital 2011 Global Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2015)... YORK , July 29, 2015 /PRNewswire/ ... a new research report "Global Industry Insight: ... to 2020" with market overview, trends, DRO analysis, ... analysis, recent developments, competitive scenario and top ... http://photos.prnewswire.com/prnh/20150727/756778 ) Microfluidic devices  ...
    (Date:7/29/2015)... LONDON , July 29, 2015 ... the Novartis transaction closed, CFO Simon Dingemans ... acquired businesses are performing in line with expectations. Ahead ... company,s commitment to sustainable innovation. The interview ... MerchantCantos produces in-depth interviews, documentaries and webcasts ...
    (Date:7/29/2015)... , July 29, 2015  Cepheid (Nasdaq: ... an update to Xpert® Carba-R, with the addition ... OXA-232.  The on-demand, molecular test also detects and ... carbapenem resistance, namely KPC, NDM, VIM, IMP-1 and ... as CROs or Superbugs, are a growing and ...
    Breaking Medicine Technology:Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 2Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 3Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 4Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 5'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4
    ... YORK, June 22, 2011 (Digital Experience!) -- iHealth ... personal healthcare products including the iHealth BP3 Blood Pressure ... announced that multiple national retail chains will now distribute ... Pressure Monitoring System is now available in all Apple ...
    ... Cempra Pharmaceuticals Inc. today announced that Prabhavathi ... the 2011 Wells Fargo Healthcare Conference at 1 p.m. ... provide an overview of the company,s two leading antibiotic ... infections and TAKSTA™ for the oral treatment of gram ...
    Cached Medicine Technology:iHealth Lab's Blood Pressure Self-Monitoring System Gets Nationwide Distribution 2
    (Date:7/29/2015)... , ... July 29, 2015 , ... It is unique ... “This is a tremendous model of care. One that is very hands on and ... executive director of Monarch Landing. “She’s bringing great passion and energy, as well as ...
    (Date:7/29/2015)... ... July 29, 2015 , ... Stealth ... a Clinical Performance Study for the Invisiport at Wheaton Franciscan Healthcare in Milwaukee, ... options, offers a less invasive, patient-friendly alternative to traditional chest ports and peripherally ...
    (Date:7/29/2015)... ... ... TransFlip is an all new dynamic transition pack for FCPX, containing flipping ... are easy to apply and modify for any skill-level user. TransFlip includes custom bounce ... kinetic flipping panel animations are just a few clicks away. , TransFlip contains over ...
    (Date:7/29/2015)... ... July 29, 2015 , ... Zofran lawsuits around the ... Multidistrict Litigation (JPML), according to court documents.* Attorneys handling Zofran lawsuits ... Birth Defects Lawsuit Center. , GlaxoSmithKline, the global pharmaceutical conglomerate and defendant in ...
    (Date:7/29/2015)... , ... July 29, 2015 , ... The New ... project, which will by the end will cost the 501(c) organization nearly $1 million, ... recent anti-ligature requirements. , “We took it down to the studs,” said Geraldine ...
    Breaking Medicine News(10 mins):Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3
    ... takes a complete snapshot of adolescent cardiovascular health in the ... likely to die of heart disease at a younger age ... "We are all born with ideal cardiovascular health, but ... health in youth," said Donald Lloyd-Jones, M.D., chair and associate ...
    ... is the recipient of one of Canada,s top awards ... the mammalian immune system, Kubes will accept the 2011 ... Canadian Institutes of Health Research (CIHR) at a ceremony ... Kubes for winning this prestigious award," said the Honourable ...
    ... Like a gardener who stakes some plants and weeds ... synapses, while pruning out redundant or unneeded synapses. Researchers ... Zhang, Ph.D., have discovered a factor in synapse-building, also ... of each other. Mammals are born with functioning ...
    ... The American Academy of Orthopaedic Surgeons (AAOS) Board of ... practice guideline (CPG) on "The Treatment of Supracondylar Humerus ... surgeon, medical director of the Trauma Program at the ... chair of the AAOS Work Group responsible for this ...
    ... Aging Society and Services and Advocacy for GLBT ... acclaimed Public Policy & Aging Report (PPAR) on ... policy and research on LGBT older adults, and current and ... "Given the voluminous gerontological literature that has built up over ...
    ... less produce the finest foie gras that rich, buttery ... eaten as slices atop lightly toasted bread scientists are ... and Food Chemistry. Caroline Molette and colleagues explain ... gras, a traditional French dish, comes from its high fat ...
    Cached Medicine News:Health News:Today's teens will die younger of heart disease 2Health News:Today's teens will die younger of heart disease 3Health News:University of Calgary researcher named Canada's Health Researcher of the Year 2Health News:University of Calgary researcher named Canada's Health Researcher of the Year 3Health News:Jackson Laboratory researchers uncover steps in synapse building, pruning 2Health News:AAOS issues new clinical practice guideline for treating common elbow fractures in children 2Health News:New report highlights LGBT older adults' needs, identifies policy opportunities 2
    For the quantitative in vitro determination of Uric Acid in serum, plasma and urine...
    For the quantitative in vitro determination of apolipoprotein A-1 (apo A-1) in serum and plasma. For use as an aid if assessing the risk of coronary artery disease....
    For the quantitative in vitro determination of Urea in serum, plasma and urine....
    The XTRI method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of triglycerides in serum and plasma....
    Medicine Products: